Initial and Follow-up Brain MRI Findings and Correlation with the Clinical Course in Wilson's Disease
Neurol 44:1064-1068, Roh,J.K.,et al, 1994
Current and Emerging Issues in Wilsons Disease
NEJM 389:922-938, Roberts,E.A. & Schilsky, M.L., 2023
Muscle Stiffness, Gait Instability, and Liver Cirrhosis in Wilsons Disease
Lancet 396:990, Kronlage, C.,et al, 2020
Wilson Disease
Yamada Textbook of Gastroenterology Chp 102, Metabolic Diseases of Liver, 6th Ed, Sunderam, S.S., & Sokol, R.J., 2016
Inherited Metabolic Diseases of the Nervous System, Hepatolenticular Degeneration (Wilson Disease)
Adams & Victors Principles of Neurology, Chp 37, pg 982, Ropper, A.H.,et al, 2014
Wilson Disease: Description of 282 Patients Evaluated Over 3 Decades
Medicine 86:112-121, Taly,A.B., et al, 2007
Proton MR Spectroscopy in Wilson Disease: Analysis of 36 Cases
AJNR 26:1066-1071, Lucato,L.T.,et al, 2005
Clinical Correlation of Brain MRI and MRS Abnormalities in Patients with Wilson Disease
Neurol 63:638-643, Page,R.A.,et al, 2004
Treatment of Wilson Disease With Ammonium Tetrathiomolybdate, III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy
Arch Neurol 60:379-385, Brewer,G.J.,et al, 2003
Diagnosis and Treatment of Wilson's Disease
Semin Neurol 19:261-270, Brewer,G.J.,et al, 1999
Wobbly Handwriting
Lancet 351:336, Rosario,M.A.F.,et al, 1998
Neurologic Presentation of Wilson Disease without Kayser-Fleischer Rings
Neurol 46:1040-1043, Demirkiran,M.,et al, 1996
Kayser-Fleischer Ring:Hepatolenticular Degeneration (Wilson's Disease)
Neurol 45:1261-1262, Finelli,P.F., 1995
Cranial MR in Wilson Disease:Abnormal White Matter in Extrapyramidal and Pyramidal Tracts
AJNR 16:2021-2027, van Wassenaer-van Hall,H.N.,et al, 1995
Treatment with D-penicillamine Improves Dopamine D2-Receptor Binding and T2-Signal Intensity in de novo Wilson's Disease
Neurol 44:1079-1082, Schwarz,J.,et al, 1994
Worsening of Neurologic Syndrome in Patients with Wilson's Disease with Initial Penicillamine Therapy
Arch Neurol 44:490-493, Brewer,G.J.,et al, 1994
Correlation of Evoked Potential and MRI Findings in Wilson's Disease
Neurol 43:2059-2064, Selwa,L.M.,et al, 1993
Wilson Disease
Medicine 71:139-164, Brewer,G.J.&Yuzbasiyan-Gurkan,V., 1992
Mid-Brain Pathology of Wilson's Disease:MRI Analysis of Three Cases
JNNP 54:624-626, Hitoshi,S.,et al, 1991
Wilson Disease:Clinical Presentation, Treatment, and Survival
Ann Int Med 115:720-726, Stremmel,W.,et al, 1991
Neurological and Neuropsychiatric Spectrum of Wilson's Disease:A Prospective Study of 45 Cases
J Neurol 238:281-287, Oder,W.,et al, 1991
Wilson's Disease
In Oxford Textbook of Clin Hepatology, Oxford Univ Press, Vol 2, Ch 20. 1, p. 947, Sternlieb,I.&Scheinberg,I.H., 1991
Evoked Potentials in Assessment and Follow-up of Patients with Wilson's Disease
Lancet 336:963-964, Grimm,G.,et al, 1990
Clinical Assessment of 31 Patients with Wilson's Disease, Correlations with Struct. Changes on MRI
Arch Neurol 44:365-370, Starosta-Rubinstein,S.,et al, 1987
Wilson's Disease Studies with FDG & Positron Emission Tomography
Neurol 37:1707-1711, Hawkins,R.A.,et al, 1987
Wilson's Disease
BMJ 288:1180-1181, Parkes,D., 1984
Penicillamine-associated Myasthenia Gravis, Antiacetylcholine Receptor & Antistriational Antibodies
Am J Med 63:689, Masters,C.L.,et al, 1977
Central Pontine Myelinolysis
Quart J Med 45:373, Tomlinson,B.E.,et al, 1976
Organic Disease Presenting as a Psychiatric Syndrome
Postgrad Med 54:78, , 1973
Diseases of the Extrapyramidal System
Disease-a-month-Jan 1970., Klawans,H.,et al, 1970
Metabolic Defects Associated with Mental Retardation
Am J Dis Child 104:401, Garell,D., 1962